Global Radiation Therapy Market: 2012 Edition

View Report Details

Global Radiation Therapy Market --------------------------------------------------2012

View Report Details Executive Summary

As the technological environment is swiftly undergoing evolution, companies operating in the healthcare/science/pharmaceutical/therapeutic industry are now scaling new heights. Also, the respective sector’s growth is boosted by the rising number of health related issues emanating from the changing lifestyle and incessantly evolving surroundings.

To address the rising demand for better healthcare options and the unmet needs within some of the underlying segments, related companies are coming up with novel and improved therapies especially in the field of cancer treatment wherein radiation therapy is gaining quick acceptance.

Radiation therapy (RT) deploys ionized radiation and limits the proliferation of malignant cells by impairing their DNA. It involves application of various types of radiations including photons, electron beams, proton beams, and neutron beams. Also, the treatment regimes are classified as external radiation therapy, internal radiation therapy or brachytherapy and systemic radioisotope therapy.

This report elicits the global radiation therapy market with focus on key regional markets like North America, EMEA, Asia Pacific and Latin America. Also, industry developments like the development of LINACs, rapid Arc therapy and proton therapy; growth drivers including rising cancer cases, increasing use of alcohol and tobacco, expanding obese population and ageing population, rising healthcare expenditure and increasing GNI; and challenges like fatal cancer types, risks associated with treatment procedure and side effects, increasing treatment costs and price pressure among others are discussed in detail. Furthermore, the competitive scenario of the global radiation therapy market, along with the profiles of top 4 industry players viz. Varian, Elekta, Siemens, and Accuray are being included in the report.

By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the industry. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables, and tests.

Radiation therapy (RT), also termed as radiation oncology/radiotherapy, deploys high energy radiation to damage cancer cells, restricting their multiplication Global Radiation Therapy Market (2001-2011) The worldwide radiation therapy market registered a compound annual growth rate of …..% from US$.....billion in 2001 to US$..... billion in 2011. The market declined by …..% from US$..... billion in 2008 to US$.....billion in 2009, on account of the global economic slowdown which affected almost all the industries worldwide.

2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001

With the ameliorating economic conditions, the number of radiation therapy procedures performed also increased and the market for radiation therapy reached US$....billion in 2011.

US$ Billion

Global Radiation Therapy Market by Region (2011)

In terms of region, North America represents the major developed market for radiation therapy world over, and it is mainly due to advancements in technology adoption. In 2011, North America constituted a major share of …..% of the global radiation therapy market, followed by the EMEA region, accounting for ……% share of the same.

 Industry Developments: -Proton Therapy -RapidArc Therapy -LINACs

Market Growth Drivers -Prevalence of Cancer -Use of alcohol and tobacco -Rising obese population and ageing population -Increasing healthcare expenditure -Demand for better healthcare options

North America

EMEA

APAC

Latin America

Factors such as increasing life expectancy rates, technology adoption and changing lifestyles are expected to increase the number of cancer patients in the developing countries North America’s Radiation Therapy Market (2001-2011) 2011 2010 2009 2008

North America is the leading market for radiation therapy all across the globe. At present, it is characterized as a replacement market.

The region accounted for around …..% share in the global radiation therapy market as of 2011. The North American RT market had grown from US$....billion in 2001 to US$.....billion in 2011, chiefly as a result of increasing cancer incidence rate as well as the favorable government reimbursements policies associated with its treatment.  The radiation therapy market in the EMEA region was valued at US$...... billion in 2001 which increased to US$...... billion in 2011.

2007 2006

The Asia Pacific region is one of the rapidly evolving markets for radiation therapy, as the low penetration rate offers huge potential for future growth. The Asia Pacific market for radiation therapy has grown with a CAGR of …….% over a ten year period from 2001 to 2011 from US$.......billion to US$..... billion.

2005 2004 2003 2002 2001

US$ Billion APAC’s Radiation Therapy Market (2001-2011) EMEA’s Radiation Therapy Market (2001-2011)

US$ Billion

US$ Billion

)

2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011

2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011

The market is highly consolidated and fiercely competitive, with the top two players accounting for roughly 78% of the total market…

Global Radiation Therapy Market Forecast (2010-2014E)

Latin America’s Radiation Therapy Market (2001-2011)

US$ Billion

2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 US$ Billion

2010

2011

2012E

2013E

2014E

 Latin America accounted for the lowest share, …..%, of the global radiation therapy market as of 2011. But, it is acknowledged as one of the key emerging markets for radiation therapy with an impeccable CAGR of ……% over a time span of ten years (2001 to 2011), offering huge growth potential in the years to come. The Latin American radiation therapy market increased from US$......billion in 2001 to US$............billion in 2011. On the competition front, Varian is the leading company in the market for radiation therapy world over, with approximately ……% of the market share for the year 2011, followed by Elekta with ……%. Siemens is the third largest company in the RT market with ………% share. Taking into account the numerous factors and growth drivers affecting the growth of global radiation therapy market, for the year 2012, the market opportunity of the same is anticipated to be US$............ billion, an estimated growth of ………% as compared to US$........... billion in 2011. The global radiation therapy market is likely to grow from US$......... billion in 2011 to US$........... billion in 2014, at a CAGR of ……….%. Key Issues faced by the respective industry include: Patient safety concerns, fatality of tumors, skyrocketing treatment costs and stringent regulatory measures

Note: Market attractiveness is inverse of penetration. Low penetration means high attractiveness and vice-versa

Table of Contents

List of Graphs & Tables

1. Radiation Therapy (RT)

List of Charts

1.1 Overview

Global Radiation Therapy Market (2001-2011) Global Radiation Therapy Market by Region (2011) Radiation Therapy Market CAGR by Region (2001-2011) Radiotherapy Equipment Order by Region (2009-2013E) North America’s Radiation Therapy Market (2001-2011) EMEA’s Radiation Therapy Market (2001-2011) APAC’s Radiation Therapy Market (2001-2011) Latin America’s Radiation Therapy Market (2001-2011) Number of Proton Therapy Centers Worldwide (2000-2011) Number of Cancer Cases Worldwide (2007-2011) Global Lung Cancer Incidences (2010 & 2030E) Global Breast Cancer Incidences (2010 & 2030E) Global Prostate Cancer Incidences (2010 & 2030E) Growth in Worldwide Obese Population (2004-2012F) Global Ageing Population (2005-2013F) Global Healthcare Spending (2005-2015E) World Gross National Income (2005-2010) Stages of a Radiotherapy Treatment Global Radiation Therapy Market Share by Company (2011) Japan’s RT Market Share by Company (FY11/12) China’s RT Market Share by Company (2011) India’s RT Market Share by Company (2011) Varian Medical Systems’ Revenue Share by Business Segments (2011) Varian Medical Systems’ Revenues and Net Earnings (2008-2011) Elekta’s Revenue Share by Business Segments (2011) Elekta’s Revenues and Profit (FY 08/09-FY 11/12) Accuracy’s Revenues and Net Income (2009-2012) Siemens AG’s Revenue Share by Business Segments (2011) Siemens AG’s Revenues and Net Income (2008-2011) Global Radiation Therapy Market Forecast (2010-2014E)

1.2 Types of Radiation Therapy 1.2.1 External-Beam Radiation Therapy 1.2.2 Internal Radiation Therapy 1.2.3 Systemic Radioisotope therapy 1.3 RT Action Mechanism 1.4 RT Effect on Different Cancer Types 2. Radiation Therapy - Market Size 2.1 Global Radiation Therapy Market Market Value Growth Rate Regional Breakdown Order Growth 2.2 Radiation Therapy Market by Region 2.2.1 North America 2.2.2 EMEA 2.2.3 APAC 2.2.4 Latin America 3. Radiation Therapy - Market Dynamics 3.1 Industry Developments 3.1.1 Development of Proton Therapy 3.1.2 Innovative RapidArc Therapy 3.1.3 Development of Linear Accelerators (LINAC)

3.2 Growth Drivers 3.2.1 Increasing Prevalence of Cancer 3.2.2 Increasing Use of Tobacco and Alcohol 3.2.3 Expanding Obese Population 3.2.4 Rising Demand for Better Healthcare Options 3.2.5 Growing Ageing Population (+60 Years) 3.2.6 Rising Healthcare Expenditure 3.2.7 Increasing Global GNI (Gross National Income)

3.3 Challenges 3.3.1 Patient Safety during the Treatment Process 3.3.2 Highly Fatal Cancers 3.3.3 Rising Costs of Treatment 3.3.4 Stringent Regulatory Measures 3.3.5 Adverse Effects of the Treatment 3.3.6 Escalating Price Pressure 4. Competitive Landscape 4.1 Competitive Scenario by Geographic Region 4.1.1 North America 4.1.2 EMEA 4.1.3 APAC 4.1.4 Japan 4.1.5 China 4.1.6 India 5. Company Profiles 5.1 Varian Medical Systems Inc. 5.1.1 Business Overview 5.1.2 Financial Overview 5.1.3 Business Strategies -Focus on Research & Development -Expanding Product Portfolio

List of Tables Estimated Cancer Cases in the US (2012) Estimated Cancer Deaths in the US (2012) Patients Worldwide Waiting for Better Treatment Options (2011) FDA Regulation of Medical Devices North America’s RT Market Share by Company (2011) EMEA’s RT Market Share by Company (2011) APAC’s RT Market Share by Company (2011) Dependent & Independent Variables (2007–2011) Correlation Matrix Model Summary – Coefficient of Determination Regression Coefficients Output

5.2 Elekta 5.2.1 Business Overview 5.2.2 Financial Overview 5.2.3 Business Strategies -Partnerships with Research Institutions -Focus on Product Development 5.3 Accuray Inc. 5.3.1 Business Overview 5.3.2 Financial Overview 5.3.3 Business Strategies -Intense Research & Development Activities -Strategic Collaborations

5.4 Siemens AG 5.4.1 Business Overview 5.4.2 Financial Overview 5.4.3 Business Strategies -Accelerating R&D Activities -Focus on Healthcare Segment 6. Market Outlook 6.1 Market Forecast 6.2 Forecast Methodology 6.2.1 Dependent and Independent Variables 6.2.2 Correlation Analysis 6.2.3 Regression Analysis

View Report Contact Us:Details These are abridged and sanitized sample pages from the comprehensive report on the “Global Radiation Therapy Market”. To know more about this report or for any customized research requirement, please contact the following:

Koncept Analytics

Vikas Gupta BD Manager

CS-36, Second Floor, Ansal Plaza Vaishali, Ghaziabad, U.P. – 201010 T. +91-120-4130959 C: +91-9811715635 vikas@konceptanalytics.com

www.konceptanalytics.com